MAPT and Alzheimer disease: Given that Αβ mouse models are not a complete model of AD, i.e. lacking Tau tangle formation and neurodegeneration, which more faithfully correlate with cognitive decline, they should be considered as models of the preclinical disease, when Αβ is first deposited.